Cell culture-based pandemic influenza vaccine: Phase III started

Vivalis S.A. (Euronext:VLS, Nantes, France) said GlaxoSmithKline and Kaketsuken began a Japanese Phase III trial to evaluate a cell culture-based pandemic flu vaccine in healthy adults. In 2009, Glax...